Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-10-16
1994-06-21
Wityshyn, Michael G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 12, 514885, 514903, 514825, 530380, 53038823, 53038824, 5303892, 436506, A61K 3700
Patent
active
053228383
ABSTRACT:
The present invention relates to the use of INHIB in the detection and inhibition of inflammation. INHIB is structurally identical to the C3 .beta.-chain.
REFERENCES:
patent: 4376110 (1983-03-01), David et al.
patent: 4645748 (1987-02-01), Hurwitz et al.
patent: 4840793 (1989-06-01), Todd, III et al.
Kuivanen, et al. Biochem. Biophys. Research Comm. 158(3), 898-905 (1989).
Milstein, et al. Nature 256, 495-7 (1975).
Muchmore, et al., Science, 229:479-81 (1985).
Seckinger, et al., J. Exp. Med., 167:1511-16 (1988).
Lin et al., Immunology, 63:663-68 (1988).
Silberstein, et al., J. Immunol., 143(3):979-83 (1989).
Silberstein, et al., J. Immunol., 142(6):2162-67 (1989).
Lamas, et al., J. Immunol., 140(5):1500-05 (1988).
Minkoff Marjorie
Silberstein David S.
Brigham & Women's Hospital
Sayala C.
Wityshyn Michael G.
LandOfFree
Use of INHIB (the C3 .beta.-chain) in the detection and inhibiti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of INHIB (the C3 .beta.-chain) in the detection and inhibiti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of INHIB (the C3 .beta.-chain) in the detection and inhibiti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2220745